Evidence-based estimates of outcome in patients irradiated for intraocular melanoma

Archives of Ophthalmology

Volumn 120, Issue 12, 2002, Pages 1665-1671

  Gragoudas, Evangelos ^a,e   Li, Wenjun ^c   Goitein, Michael ^b   Lane, Anne Marie ^a   Munzenrider, John E ^b   Egan, Kathleen M ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CAUSE OF DEATH; CHOROID MELANOMA; CILIARY BODY; EYE CANCER; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; RISK ASSESSMENT; SALVAGE THERAPY; SCHOOL CHILD; SCORING SYSTEM; TUMOR RECURRENCE; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0036969210     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.120.12.1665     Document Type: Article

References (51)

1. Scotto J, Fraumeni J Jr, Lee J. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 1976;56:489-491.
2. Damato B, Foulds WS. Indications for trans-scleral local resection of uveal melanoma. Br J Ophthalmol 1996;80:1029-1030.
3. Meyer-Schwickerath G, Vogel M. Treatment of malignant melanomas of the choroid by photocoagulation. Trans Ophthalmol Soc U K. 1977;97:416-420.
4. Peyman G, Raichand M. Full-thickness eye wall resection of choroidal neoplasms. Ophthalmology. 1979;86:1024-1036.
5. Shields JA, Augsburger JJ, Brady LW, Day JL. Cobalt plaque therapy of posterior uveal melanomas. Ophthalmology. 1982;89:1201-1207.
6. Packer S, Rotman M. Radiotherapy of choroidal melanoma with iodine-125. Ophthalmology. 1980;87:582-590.
7. Lommatzsch P. Beta-irradiation of choroidal melanoma with 106Ru/106Rh applicators: 16 years' experience. Arch Ophthalmol. 1983;101:713-717.
8. Char DH, Castro JR. Helium ion therapy for choroidal melanoma. Arch Ophthalmol. 1982;100:935-938.
9. Gragoudas ES, Goitein M, Verhey L, et al. Proton beam irradiation of uveal melanomas: results of 5 1/2-year study. Arch Ophthalmol. 1982;100:928-934.
10. Egger E, Schalenbourg A, Zografos L, et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys. 2001;51:138-147.
11. Koehler A, Schneider R, Sisterson J. Range modulators for protons and heavy ions. Nucl Instrum Methods. 1975;131:437-440.
12. Gragoudas ES, Goitein M, Koehler AM, et al. Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol. 1977;83:665-673.
13. Li W, Judge H, Gragoudas ES, Seddon JM, Egan KM. Patterns of tumor initiation in choroidal melanoma. Cancer Res. 2000;60:3757-3760.
14. Gragoudas E, Goitein M, Koehler A, et al. Proton irradiation of choroidal melanomas: preliminary results. Arch Ophthalmol. 1978;96:1583-1591.
15. Gragoudas ES, Seddon J, Goitein M, et al. Current results of proton beam irradiation of uveal melanomas. Ophthalmology. 1985;92:284-291.
16. Curb JD, Ford CE, Pressel S, Palmer M, Babcock C, Hawkins CM. Ascertainment of vital status through the National Death Index and the Social Security Administration. Am J Epidemiol 1985;121:754-766.
17. Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994;140:1016-1019.
18. Sesso HD, Paffenbarger RS, Lee IM. Comparison of National Death Index and World Wide Web death searches. Am J Epidemiol. 2000;152:107-111.
19. Cox D. Regression models and life-tables. J R Stat Soc Ser B. 1972;34:187-220.
20. Hess KR. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med. 1995;14:1707-1723.
21. Garrett JM. Graphical assessment of the Cox model proportional hazards assumption. Stata Technical Bull. 1997;35:9-14.
22. Gramsbsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
23. Cochran AJ, Elashoff D, Morton DL, Elashoff R. Individualized prognosis for melanoma patients. Hum Pathol. 2000;31:327-331.
24. Lin D, Wei L. The robust inference for the Cox proportional hazards model. J Am Stat Assoc. 1989;84:1074-1078.
25. Ghoneim MA, El-Mekresh MM, Mokhtar AA, Gomha MA, El-Baz MA, El-Attar IA. A predictive model of survival after radical cystectomy for carcinoma of the bladder. BJU Int. 2000;85:811-816.
26. Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999;189:291-299.
27. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000; 191:389-394.
28. Gragoudas ES, Lane AM, Regan S, et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000; 118:773-778.
29. Meecham W, Char D, Kroll S, Castro J, Blakely E. Anterior segment complications after helium ion radiation therapy for uveal melanoma: radiation cataract. Arch Ophthalmol. 1994;112:197-203.
30. Gragoudas ES, Egan KM, Walsh SM, Regan S, Munzenrider JE, Taratuta V. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol. 1995;119:157-164.
31. Kim M, Char D, Castro J, Saunders W, Chen G, Stone R. Neovascular glaucoma after helium ion irradiation for uveal melanoma. Ophthalmology. 1986;93:189-193.
32. Summanen P, Immonen I, Kivela T, Tommila P, Heikkonen J, Tarkkanen A. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. Br J Ophthalmol. 1996;80:732-739.
33. Daftari IK, Char DH, Verhey LJ, et al. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. Int J Radiat Oncol Biol Phys. 1997;39:997-1010.
34. Augsburger JJ, Shields JA. Cataract surgery following cobalt-60 plaque radiotherapy for posterior uveal malignant melanoma. Ophthalmology. 1985;92:815-822.
35. Fish GE, Jost BF, Snyder WI, Fuller DG, Birch DG. Cataract extraction after brachytherapy for malignant melanoma of the choroid. Ophthalmology. 1991;98:619-622.
36. Gragoudas ES, Egan KM, Arrigg PG, Seddon JM, Glynn RJ, Munzenrider JE. Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol. 1992;110:475-479.
37. Guyer D, Mukai S, Egan K, Seddon J, Walsh S, Gragoudas E. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology. 1992;99:1278-1285.
38. Gunduz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol. 1999;117:609-614.
39. Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology. 1999;106:1571-1578.
40. Kellner U, Bornfeld N, Foerster MH. Radiation-induced optic neuropathy following brachytherapy of uveal melanomas. Graefes Arch Clin Exp Ophthalmol. 1993; 231:267-270.
41. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol. 2000; 118:1219-1228.
42. Augsburger JJ, Goel SD. Visual function following enucleation or episcteral plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol. 1994;112:786-789.
43. Melia BM, Abramson DH, Albert DM, et al. Collaborative Ocular Melanoma Study (COMS) randomized trial of 1-125 brachytherapy for medium choroidal melanoma, I: visual acuity after 3 years: COMS report No. 16. Ophthalmology. 2001; 108:348-366.
44. Char D, Quivey J, Castro J, Kroll S, Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma: a prospective, randomized, dynamically balanced trial. Ophthalmology. 1993;100:1547-1554.
45. Hill J, Sealy R, Shackleton D, et al. Improved iodine-125 plaque design in the treatment of choroidal malignant melanoma. Br J Ophthalmol. 1992;76:91-94.
46. Seigel D, Myers M, Ferris F III, Steinhorn SC. Survival rates after enucleation of eyes with malignant melanoma. Am J Ophthalmol. 1979;87:761-765.
47. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma, II: a meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992;110:245-250.
48. Seddon JM, Gragoudas ES, Egan KM, et al. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology. 1990;97:769-777.
49. Augsburger J, Gamel J, Sardi V, Greenberg R, Shields J, Brady L. Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol. 1986;104:655-661.
50. Adams K, Abramson D, Ellsworth R, et al. Cobalt plaque versus enucleation for uveal melanoma: comparison of survival rates. Br J Ophthalmol. 1988;72:494-497.
51. Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings: COMS Report No. 18. Arch Ophthalmol. 2001;119:969-982.